Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 6.69%
- Poor long term growth as Net Sales has grown by an annual rate of 13.00% and Operating profit at 7.83% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.33 times
Negative results in Sep 25
38.76% of Promoter Shares are Pledged
Stock DNA
Paper, Forest & Jute Products
INR 25 Cr (Micro Cap)
15.00
17
0.00%
0.57
3.74%
0.55
Total Returns (Price + Dividend) 
Sangal Papers for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Sangal Papers Faces Intense Selling Pressure Amid Consecutive Losses
Sangal Papers Ltd is currently experiencing significant selling pressure, with the stock registering only sell orders and no buyers in the queue. This extreme market behaviour signals distress selling, as the company’s shares continue to face consecutive losses over multiple time frames despite outperforming the broader Sensex index on the day.
Read More
Sangal Papers Faces Intense Selling Pressure Amid Consecutive Losses
Sangal Papers Ltd is experiencing severe selling pressure, with the stock hitting a lower circuit and only sell orders visible in the queue. The paper industry player has recorded consecutive declines, signalling distress selling and a lack of buyer interest amid a challenging market environment.
Read More
Sangal Papers Surges to Upper Circuit Amid Unprecedented Buying Interest
Sangal Papers witnessed extraordinary buying momentum today, hitting the upper circuit with only buy orders in the queue and no sellers willing to transact. This rare market phenomenon signals intense demand and could potentially extend the circuit limit for multiple days, marking a significant event in the Paper, Forest & Jute Products sector.
Read More Announcements 
Board Meeting Intimation for Intimation Of Board Meeting For Approval Of Unaudited Results For The Quarter Ended On 31.12.2025.
31-Jan-2026 | Source : BSESangal Papers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Intimation of board meeting for approval of un-audited results for the quarter ended on 31.12.2025
Announcement Under Regulation 30 Of SEBI(LODR) Regulations 2015.
30-Jan-2026 | Source : BSEAnnouncement under Regulation 30 of SEBI (LODR) Regulations 2015.
Announcement Under Regulation 30 Of SEBI(LODR)
29-Jan-2026 | Source : BSEAnnouncement under Regulation 30 of SEBI (LODR)Regulations 2015.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
38.7565
Held by 0 Schemes
Held by 0 FIIs
Amit Sangal (9.26%)
Mahendra Girdharilal (2.72%)
58.5%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 1.64% vs 1.62% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -62.50% vs 86.05% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 2.27% vs -2.40% in Sep 2024
Growth in half year ended Sep 2025 is -50.22% vs 384.78% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is -5.80% vs -14.84% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 49.07% vs -41.67% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -5.29% vs -15.82% in Mar 2024
YoY Growth in year ended Mar 2025 is 14.57% vs -27.14% in Mar 2024